Obesity drugs regulate neural systems to curb appetite, research reveals

A recent Northwestern Medicine study has identified novel neural circuits modulated by the diabetes and obesity-management drugs semaglutide and tirzepatide that help suppress appetite, according to findings published in The Journal of Clinical Investigation.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup